Dendritic cells in cancer immunotherapy: vaccines or autologous transplants? Jun 2011 - :1559-0755 [PMID:21717071] [Kalinski P] [Edington H] [Zeh HJ] [Okada H] [Butterfield LH] [Kirkwood JM] [Bartlett DL]
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. Jan 2011 - J. Clin. Oncol.; 29(3):1527-7755 [PMID:21149657] [Okada H] [Kalinski P] [Ueda R] [Hoji A] [Kohanbash G] [Donegan TE] [Mintz AH] [Engh JA] [Bartlett DL] [Brown CK] [Zeh H] [Holtzman MP] [Reinhart TA] [Whiteside TL] [Butterfield LH] [Hamilton RL] [Potter DM] [Pollack IF] [Salazar AM] [Lieberman FS]
Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors. Apr 2010 - :1096-3618 [PMID:20409732] [Kalinski P] [Okada H]
Brain tumor immunotherapy with type-1 polarizing strategies. Sep 2009 - Ann. N. Y. Acad. Sci.; 1174:1749-6632 [PMID:19769732] [Okada H]
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas. Feb 2008 - J Transl Med; 5:1479-5876 [PMID:18093335] [Okada H] [Lieberman FS] [Walter KA] [Lunsford LD] [Kondziolka DS] [Bejjani GK] [Hamilton RL] [Torres-Trejo A] [Kalinski P] [Cai Q] [Mabold JL] [Edington HD] [Butterfield LH] [Whiteside TL] [Potter DM] [Schold SC] [Pollack IF]
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics. Jan 2007 - Clin. Cancer Res.; 13(2 Pt 1):1078-0432 [PMID:17255279] [Zhang JG] [Eguchi J] [Kruse CA] [Gomez GG] [Fakhrai H] [Schroter S] [Ma W] [Hoa N] [Minev B] [Delgado C] [Wepsic HT] [Okada H] [Jadus MR]
